| 13:30-13:35 | 致辞 |
临床药理分会场开幕式 |
|
||||
| 13:35-14:05 | 专题报告 |
DeepRare智能体在儿科疾病中的应用前景 |
|
||||
| 14:05-14:35 | 专题报告 |
儿童抗菌药物监测情况 |
|
||||
| 14:35-15:05 | 专题报告 |
儿童临床个体化用药的思考 |
|
||||
| 15:10-15:15 | 讨论 |
集体答疑、讨论 |
|||||
| 15:15-15:23 | 大会发言 |
Precision Antimicrobial Therapy Guided by Bronchoalveolar Lavage Fluid Microbiological Analysis in Infants with Non-Atopic Chronic Wheezing: A Retrospective Cohort Study |
|
||||
| 15:23-15:31 | 大会发言 |
儿科药学门诊现状评价:一项基于儿科药师的横断面调查研究 |
|
||||
| 15:31-15:39 | 大会发言 |
Efficacy and Timing of Doxycycline Use in the Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia with A2063G Mutations in Children |
|
||||
| 15:39-15:47 | 大会发言 |
基于多数据库回顾性队列的PICU肺炎患儿万古霉素治疗期间急性肾损伤发生率及其相关因素分析 |
|
||||
| 15:47-15:55 | 大会发言 |
A multicenter randomized controlled study of vancomycin in the treatment of severe infection in children according to pharmacokinetics |
|
||||
| 15:55-16:03 | 大会发言 |
中国多中心儿童重症监护病房抗菌药物应用在WHO AWaRe中的分布 |
|
||||
| 16:03-16:11 | 大会发言 |
基于真实世界数据的万古霉素儿科临床应用有效性与安全性研究 |
|
||||
| 16:11-16:19 | 大会发言 |
低剂量阿奇霉素在T2-low型较T2-high型儿童难治性哮喘中的表型特异性免疫调节药理反应:一项真实世界观察性研究 |
|
||||
| 16:19-16:27 | 大会发言 |
基于混合分析策略的尼塞韦单抗真实世界多维药物警戒研究 |
|
||||
| 16:27-16:35 | 大会发言 |
从PPK模型到专家共识:一名年轻药师的成长之路———儿童急性血源性骨髓炎万古霉素个体化用药的多点实践 |
|
||||
| 16:35-16:43 | 大会发言 |
Implementation Status of Model-Informed Precision Dosing in Chinese Hospitals: A Cross-Sectional Study |
|
||||
| 16:43-16:51 | 大会发言 |
门诊呼吸道合胞病毒感染患儿抗菌药物使用情况及影响因素分析 |
|
||||
| 16:51-17:00 | 讨论 |
集体答疑、讨论 |
|||||